The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Top Cited Papers
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 14 (9) , 413-420
- https://doi.org/10.1016/j.tim.2006.07.008
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Minimising antibiotic resistanceThe Lancet Infectious Diseases, 2005
- Resistance to Cefepime and Cefpirome Due to a 4-Amino-Acid Deletion in the Chromosome-Encoded AmpC β-Lactamase of a Serratia marcescens Clinical IsolateAntimicrobial Agents and Chemotherapy, 2004
- Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter SpeciesArchives of internal medicine (1960), 2002
- Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter sppAntimicrobial Agents and Chemotherapy, 2001
- Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of anEnterobacter cloacaeclinical isolateFEMS Microbiology Letters, 2001
- Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases.Journal of Antimicrobial Chemotherapy, 1997
- AmpD, essential for both β‐lactamase regulation and cell wall recycling, is a novel cytosolic N‐acetylmuramyl‐L‐alanine amidaseMolecular Microbiology, 1995
- In-vitro evaluation of the four β-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactamJournal of Antimicrobial Chemotherapy, 1993
- Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1991
- Function of the Outer Membrane of Escherichia coli as a Permeability Barrier to Beta-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 1977